As of 12:16pm ET
| +0.025 / +0.95%|
The 4 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 3.75. The median estimate represents a +79.25% increase from the last price of 2.65.
The current consensus among 4 polled investment analysts is to Buy stock in NovaBay Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.